Central Asset Investments & Management Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-350
Closed -$289K 47
2025
Q1
$289K Hold
350
0.49% 37
2024
Q4
$270K Buy
+350
New +$290K 0.17% 64
2024
Q3
Sell
-600
Closed -$543K 55
2024
Q2
$543K Hold
600
0.2% 32
2024
Q1
$467K Hold
600
0.38% 34
2023
Q4
$350K Buy
+600
New +$350K 0.35% 34

Other funds holding LLY

Central Asset Investments & Management Holdings's LLY Position: Q2 2025 in Review

Central Asset Investments & Management Holdings sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 350 shares — an estimated $289K sold.

Central Asset Investments & Management Holdings first reported a position in LLY in Q4 2023 and held it in 5 quarters. The position peaked at $543K in Q2 2024. 3,908 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Central Asset Investments & Management Holdings reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Central Asset Investments & Management Holdings sold 350 Eli Lilly shares in Q2 2025, an estimated $289K.
  • Central Asset Investments & Management Holdings first reported a position in Eli Lilly in Q4 2023 and held it in 5 quarters.
  • Central Asset Investments & Management Holdings's Eli Lilly position peaked at $543K in Q2 2024.
  • 3,908 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Central Asset Investments & Management Holdings's 13F filing for Q2 2025, filed 8 Aug 2025.